Anisomycin protects cortical neurons from prolonged hypoxia with differential regulation of p38 and ERK

Brain Research

Volumn 1149, Issue 1, 2007, Pages 76-86

  Hong, Soon Sun ^a   Qian, Hong ^a   Zhao, Peng ^a   Bazzy Asaad, Alia ^a   Xia, Ying ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anisomycin; Delta opioid receptor; ERK; Hypoxia; JNK; p38

Indexed keywords

ANISOMYCIN; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NALTRINDOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN HYPOXIA; BRAIN INJURY; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; IMMUNOBLOTTING; IMMUNOREACTIVITY; NERVE CELL CULTURE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; ANISOMYCIN; CELL HYPOXIA; CELLS, CULTURED; CEREBRAL CORTEX; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FETUS; IMMUNOBLOTTING; NALTREXONE; NARCOTIC ANTAGONISTS; NEURONS; NEUROPROTECTIVE AGENTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS;

EID: 34247466494     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.02.062     Document Type: Article

References (43)

1. Barancik M., Htun P., and Schaper W. Okadaic acid and anisomycin are protective and stimulate the SAPK/JNK pathway. J. Cardiovasc. Pharmacol. 34 (1999) 182-190
2. Borlongan C.V., Wang Y., and Su T.P. Delta opioid peptide (d-Ala 2, d-Leu 5) enkephalin: linking hibernation and neuroprotection. Front. Biosci. 9 (2004) 3392-3398
3. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37-40
4. Dessi F., Charriaut-Marlangue C., and Ben-Ari Y. Anisomycin and cycloheximide protect cerebellar neurons in culture from anoxia. Brain Res. 581 (1992) 323-326
5. Dhawan P., Bell A., Kumar A., Golden C., and Mehta K.D. Critical role of p42/44(MAPK) activation in anisomycin and hepatocyte growth factor-induced LDL receptor expression: activation of Raf-1/Mek-1/p42/44(MAPK) cascade alone is sufficient to induce LDL receptor expression. J. Lipid Res. 40 (1999) 1911-1919
6. Dougherty C.J., Kubasiak L.A., Prentice H., Andreka P., Bishopric N.H., and Webster K.A. Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress. Biochem. J. 362 (2002) 561-571
7. Fukuda K., Kato S., Morikawa H., Shoda T., and Mori K. Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J. Neurochem. 67 (1996) 1309-1316
8. Harada J., and Sugimoto M. An inhibitor of p38 and JNK MAP kinases prevents activation of caspase and apoptosis of cultures cerebellar granule neurons. Jpn. J. Pharmacol. 79 (1999) 369-378
9. Hazzalin C.A., Le Panse R., Cano E., and Mahadevan L.C. Anisomycin selectively desensitizes signaling components involved in stress kinase activation and fos and jun induction. Mol. Cell. Biol. 18 (1998) 1844-1854
10. Hong S.S., Gibney G.T., Esquilin M., Yu J., and Xia Y. Effect of protein kinases on lactate dehydrogenase activity in cortical neurons during hypoxia. Brain Res. 1009 (2004) 195-202
11. Horstmann S., Kahle P.J., and Borasio G.D. Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro. J. Neurosci. Res. 52 (1998) 483-490
12. Jin N., Hatton N., Swartz D.R., Xia X., Harrington M.A., Larsen S.H., and Rhoades R.A. Hypoxia activates jun-N-terminal kinase, extracellular signal-regulated protein kinase, and p38 kinase in pulmonary arteries. Am. J. Respir. Cell Mol. Biol. 23 (2000) 593-601
13. Jin K., Mao X.O., Zhu Y., and Greenberg D.A. MEK and ERK protect hypoxic cortical neurons via phosphorylation of Bad. J. Neurochem. 80 (2002) 119-125
14. Kharlamov E., Cagnoli C.M., Atabay C., Ikonomovic S., Grayson D.R., and Manev H. Opposite effect of protein synthesis inhibitors on potassium deficiency induced apoptotic cell death in immature and mature neuronal cultures. J. Neurochem. 65 (1995) 1395-1398
15. Kramer H.K., and Simon E.J. mu and delta-Opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization. Neuropharmacology 39 (2000) 1707-1719
16. Lim Y.J., Zheng S., and Zuo Z. Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions. Anesthesiology 100 (2004) 562-568
17. Luft A.R., Buitrago M.M., Ringer T., Dichgans J., and Schulz J.B. Motor skill learning depends on protein synthesis in motor cortex after training. J. Neurosci. 24 (2004) 6515-6520
18. Ma M.C., Qian H., Ghassemi F., Zhao P., and Xia Y. Oxygen sensitive d-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J. Biol. Chem. 280 (2005) 16208-16218
19. Mackay K., and Mochly-Rosen D. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J. Biol. Chem. 274 (1999) 6272-6279
20. Marais E., Genade S., Huisamen B., Strijdom J.G., and Moolman J.A. Activation of p38 MAPK induced by a multi-cycle ischaemic reconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion. J. Mol. Cell. Cardiol. 33 (2001) 769-778
21. Maroney A.C., Glicksman M.A., Basma A.N., et al. Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J. Neurosci. 18 (1998) 104-111
22. Obata K., Yamanaka H., Kobayashi K., Dai Y., Mizushima T., Katsura H., Fukuoka T., Tokunaga A., and Noguchi K. Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation. J. Neurosci. 24 (2004) 10211-10222
23. Pi R., Li W., Lee N.T., Chan H.H., Pu Y., Chan L.N., Sucher N.J., Chang D.C., Li M., and Han Y. Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways. J. Neurochem. 91 (2004) 1219-1230
24. Polakiewicz R.D., Schieferl S.M., Gingras A.C., Sonenberg N., and Comb M.J. mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J. Biol. Chem. 273 (1998) 23534-23541
25. Schaeffer H.J., and Weber M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19 (1999) 2435-2444
26. Schneiders S., Chen W., Hou J., Steenbergen C., and Murphy E. Inhibition of p38 MAPK a/b reduces ischemic injury and does not block the protective effects of preconditioning. Am. J. Physiol. 280 (2001) H499-H580
27. Seger R., and Krebs E.G. The MAPK signaling cascade. FASEB J. 9 (1995) 726-735
28. Serbest G., Horwitz J., Jost M., and Barbee K. Mechanisms of cell death and neuroprotection by poloxamer 188 after mechanical trauma. FASEB J. 20 (2006) 308-310
29. Shahabi N.A., Daaka Y., McAllen K., and Sharp B.M. Delta opioid receptors expressed by stably transfected Jurkat cells signal through the map kinase pathway in a ras-independent manner. J. Neuroimmunol. 94 (1999) 48-57
30. Shifrin V.I., and Anderson P. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J. Biol. Chem. 274 (1999) 13985-13992
31. Skaper S.D., and Walsh F.S. Neurotrophic molecules: strategies for designing effective therapeutic molecules in neurodegeneration. Mol. Cell. Neurosci. 12 (1998) 179-193
32. Steenbergen C. The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury; relationship to ischemic preconditioning. Basic Res. Cardiol. 97 (2002) 276-285
33. Sweatt J.D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 76 (2001) 1-10
34. Torocsik B., and Szeberenyi J. Anisomycin affects both pro- and antiapoptotic mechanisms in PC12 cells. Biochem. Biophys. Res. Commun. 278 (2000) 550-556
35. Xia Y., and Haddad G.G. Ontogeny and distribution of opioid receptors in the rat brainstem. Brain Res. 549 (1991) 181-193
36. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
37. Yang D.D., Kuan C.Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., Rakic P., and Flavell R.A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389 (1997) 865-870
38. Yellon D.M., and Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol. Rev. 83 (2003) 1113-1151
39. Zhang Z., Xin S.M., Wu G.X., Zhang W.B., Ma L., and Pei G. Endogenous deltaopioid and ORL1 receptors couple to phosphorylation and activation of p38 MAPK in NG108-15 cells and this is regulated by protein kinase A and protein kinase C. J. Neurochem. 73 (1999) 1502-1509
40. Zhang J., Haddad G.G., and Xia Y. δ-, not μ- and κ-, Opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury. Brain Res. 885 (2000) 143-153
41. Zhang J., Gibney G.T., Zhao P., and Xia Y. Neuroprotective role of delta-opioid receptors in cortical neurons. Am. J. Physiol.: Cell Physiol. 282 (2002) C1225-C1234
42. Zhang J., Qian H., Zhao P., Hong S.S., and Xia Y. Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through δ-opioid receptor. Stroke 37 (2006) 1094-1099
43. Zheng S., and Zuo Z. Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Mol. Pharmacol. 65 (2004) 1172-1180